Capricorn Scientific
CHOventure Growth Medium
High-Yield Protein Production with CHO Cells for Biopharmaceutical Applications
CHOventure is a comprehensive, chemically defined media system designed to maximize protein yield and quality in CHO fed-batch systems. It provides high-performance growth medium with two feeds, available in liquid and powder formats. Developed by Capricorn Scientific and ExcellGene through a strategic collaboration, it combines Capricorn’s expertise in manufacturing with ExcellGene’s outstanding track record in cell line and process development.
Support is provided from the initial idea to market entry, ensuring a seamless experience with CHOventure. From effortless adaptation and efficient scale-up to high-yield production, CHOventure offers unmatched performance. This collaboration brings extensive knowledge of CHO growth and expression, expediting the journey to success.
Key benefits of CHOventure include superior growth with viable cell densities of up to 25 million cells/ml, high productivity with protein yields of up to 15 g/L, and seamless scalability from small-scale experiments to large-scale expression.
Product classification CHOventure Growth Medium
Product categories
Applications
Manufacturers of similar products
Find more cell culture media and related products
Find CHOventure Growth Medium and related products in the theme worlds
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
Last viewed contents
Thermo Fisher Scientific - Breda, Netherlands
Shimadzu Europa GmbH - Duisburg, Germany
NextGen Sciences Strengthens Protein Biomarker Team with Two Key Appointments
Neuenhauser Automation GmbH - Naila, Germany
Cancilico Raises €2.5M to Scale AI-Powered Bone Marrow Diagnostics - “We are facing a global shortage of hematologists, yet the complexity of diagnostic cases is rising”
List_of_images_in_Gray's_Anatomy:_IV._Myology
HOX Life Science GmbH - Frankfurt am Main, Germany
PET tracer can measure damage from multiple sclerosis in mouse models
Holographic analysis of single cells - Native and staining-free pharmacologic assessment of drug dose responses
Acambis announces significant progress on its MVA smallpox vaccine programme
